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Traditional medicinesThe aim of the study was to determine the possible cytotoxicity of the aqueous stem bark extracts of Prunus
africana and Warburgia ugandensis to Vero E6 cells and acute toxicity in BALB/c mice. Despite being some of
the most popular medicinal plants used in Africa, little is known about the safety. In-vitro cytotoxicity tests on
Vero E6 cells were investigated using MTT assay to assess the safety of the two plant extracts. Vero E6 cells on
growing to conﬂuence were incubated with different drug concentrations for 48 h for the drug to take effect. Vi-
ability of the cells was measured by a scanning multiwell spectrophotometer, color intensity being equivalent to
viable cells which reduce MTT to soluble formazan crystals. This was done by determining the CC50 of the ex-
tracts, CC50 being the concentration of the dose of the compound/extract that kills 50% of the cells. In acute tox-
icity a total of 55 mice were used. Mice were divided into eleven groups of 5 mice, one group served as negative
control and ten groups received oral gavage doses at 500, 889.56, 1581.6, 2812.15 or 5000 mg/kg body weight
once. Mortality and other signs of toxicity were recorded within 24 h and the weights of the surviving mice
taken for 14 days thereafter. P. africana had CC50 of 104.08 μg/ml while W. ugandensis had CC50 N 250 μg/ml
and both were classiﬁed as not cytotoxic. There was no mortality observed in groups of mice that received P. af-
ricana extracts at 500 and 889.56 mg/kg body weight. There was 20%, 60% and 100% mortality observed within
24 h formice that received P. africana extracts at 1581.64, 2812.15 and 5000 mg/kg bodyweight respectively. Le-
thal dose (LD50) for P. africana was 2201.207 mg/kg body weight. W. ugandensis extracts had no mortality
recorded in all dose levels and the LD50 was N5000 mg/kg body weight. The weights of mice that survived the
entire 14 days in all groups increased and were not signiﬁcantly different from that of controls p N 0.05. From
the in vitro and in vivo studies, the two extracts were safe to use. Though with their customary value among
manyKenyan communities inmanagement of asthma among other ailments there is a need for further validation
of any anti-asthmatic properties and responsible chemical compounds to augment the ﬁndings.
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
More than 60% of the world's population of which over 80% are in
the developing countries depend upon traditional medicine for their
primary health care (Bannerman et al., 1983). The knowledge of medic-
inal plants and their roles in treatment of diseases are individually held
by the traditional health practitioners (THP). The information on the use
of the herbal remedies was bequeathed to them by their fathers orally
from generation to generation. Although herbal medication is thought
to bemore effective andhaving fewer side effects compared to synthetic
medicines, self-prescription is a common practice inmost rural commu-
nities. Adverse effects of these herbal therapies and sometimes life-
threatening conditions have been noted among some ethnic communi-
ties (Chan, 2003; Elvin-Lewis, 2001). Scientiﬁc ﬁndings and the World
Health Organization (WHO) specify that, many plants used as foodicine and Infectious Diseases-
f Agriculture and Technology
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y Elsevier B.V. All rights reserved.and traditional medicine are potentially toxic, mutagenic and carcino-
genic (Schimmer et al., 1994). Since few studies have been undertaken
to ascertain the safety of traditional remedies, it is necessary to deter-
mine both efﬁcacy and toxicity proﬁle of medicinal plants prior to put-
ting them to clinical use.
Prunus africana is commonly known as Pygeum or African cherry
and it is in the Family Rosaceae (Kokwaro, 1976). Stem bark water ex-
tracts are traditionally used as an expectorant for disorders of the
chest and lungs (Kokwaro, 1976). It is widely distributed in several
provinces of Kenya though it is predominant in Mount Kenya forest
and the environs. It is here where the herbal extract prepared from
the bark of P. africana, is used as an alternative medicine for many ail-
ments among them asthma and chest complications. These stem bark
water extracts are used without scientiﬁc assessment of their safety
and efﬁcacy. Conversely,W. ugandensis is a species of evergreen tree na-
tive to Africa. The stem and roots ofW. ugandensis are used as expecto-
rant, for the common cold and against fever, malaria, stomachache,
constipation and diarrhea (El Kamali and El kijalifa, 1997). Observation-
al studies by clinicians indicate that people customarily use the plants-
derived preparations for bronchial asthma management and that the
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these observational ﬁndings it was apparent that these plant prepara-
tions are taken without any scientiﬁc screening for efﬁcacy and safety.
Due to the increased use of the stem bark extracts of the two plants tra-
ditionally in management of asthma, there was an ostensive need to
carry out a comprehensive study on their toxicity to highlight any pos-
sible hidden toxic activity. This studywas therefore designed to investi-
gate the in vitro effect of the stem bark extracts to the Vero E6 cells and
acute toxicity to BALB/c mice.
2. Materials and methods
2.1. Experimental animals
Eight week old healthy female BALB/c mice with a mean body
weight of 20 ± 2 g bred at KEMRI, Nairobi, Kenya were used for
the study. The animals were moved into the experimental room for
acclimatization one week before onset of experiments. Five mice
were housed in 15 cm × 21 cm × 29 cm transparent plastic cages
bedded with wood shavings and equipped with continuous-ﬂow
nipple watering devices. They were feed with pellets (Mice pellets
UNGA® feeds) and water ad libitum.
2.2. Experimental procedures
2.2.1. Collection of the medicinal plants
The medicinal plants were collected in August 2012 from their
natural habitats in Meru forest Kenya. This was done with the assis-
tance of a plant taxonomist/botanist. Five kilograms of fresh plant
parts (stem barks) was collected and packaged in gunny bags. Accept-
able bio-conservation/sustainable harvesting techniques such as
peeling patches of barks from different sites on the tree/not cutting
down the tree were applied (Harnischfeger, 2000). Voucher speci-
mens were deposited at the East African Herbarium (voucher num-
bers, Table 1), National Museums of Kenya, Nairobi, Kenya. Plants
of study are shown in Appendices A and B.
2.2.2. Preparation of plant extracts by water extraction
Clean stem barks were air-dried at room temperature under shade
for 14 days and pulverized using a laboratory mill (Christy & Norris
Ltd., Chelmsford, England). A hundred and ﬁfty grams of the powdered
plant material was extracted with 1500 ml of distilled water in a water
bath at 60 °C for 1 h. The extracts were ﬁltered and freeze dried using a
Freeze Dryer (Edwards freeze dryerModulyo). The freeze dried powder
was weighed, labeled and stored in an airtight bijou bottle at 4 °C.
2.2.3. Preparation of plant extracts for in vitro bioassays
The water extracts of the plant samples prepared earlier, were
retrieved from 4 °C and dissolved in distilled water so that the ﬁnal
highest concentration in the microtiter plates was 250 μg/ml. For
these experiments 250 mg of the water extract was dissolved in
1 ml DMSO to form a stock solution of 10,000 μg/ml in 100% DMSO.
This was diluted in media in a ratio of 1:100 that is 10 μl of extract
in 990 of media to give a start concentration of 250 μg/ml in 1%
DMSO. Each of the extracts was ﬁlter sterilized with syringe adapt-
able 0.22 μm ﬁlters into sterile Bijou bottles in the laminar ﬂow
hood (Bello Glasses Inc., USA) and stored at−20 °C).Table 1
Plant species, voucher numbers and parts collected.
Botanical name Family Voucher number Part used
Prunus africana Rosaceae TFm10 Stem bark
Warburgia ugandensis Magnoliidae TFm11 Stem bark2.2.4. Cytotoxicity assay of the extracts in cell culture
In vitro cytotoxicity assay was carried out following a modiﬁed
rapid calorimetric assay as described byMosmann (1983) using actively
dividing sub-conﬂuent Vero E6 cells. Vero E6 cells were chosen in this
study due to their sensitivity (quite fragile/delicate), subsequently if
the drugs are not cytotoxic to them, the drugs are then safe in other
cells which are more resistant (McGuinness and Mantis, 2006; Pauly
et al., 2009, 2012). The Vero cells were maintained in Eagle's Minimum
Essential Medium (MEM) containing 10% fetal bovine serum (FBS),
in T-75 cell culture ﬂasks incubated at 37 °C in 5% CO2. Upon attainment
of conﬂuence, cells were detached by trypsinization and pooled in a
50 ml tube. The cells were then re-suspended in 40 ml fresh MEM. A
100 μl of cell suspension of 2 × 105 was seeded in 96-well microtiter
plates in columns 1, 2, 4, 5, 7, 8, 10 and 11 in wells of rows A–H and
incubated at 37 °C/5% CO2 for 12 h. Cells without drugs (row A)
served as negative controls while wells with no cells (columns 3, 6, 9
and 12) served as blanks. The cells were incubated overnight (24 h
period) to allow cells to attach. The next day the media was removed
from row H and care was taken not to leave cells without media for
too long. Addition of 150 μl of 250 μg/1 ml DMSO of the highest drug
concentration in triplicate (4 drugs per plate) was done in rowH. Serial
dilutions using amulti-channel pipette by removing 50 μl fromwells
of row H and adding to wells of row G were carried out. After mixing
well, another 50 μl was transferred from row G to wells of row F and
mixed well. This was continued up to row B discarding the last 50 μl
of this row; leaving out row A (a threefold dilution is achieved). Row
A wells were exempted since they served as controls (wells without
drugs). Thus row H wells had a concentration of 250 μg/ml, G wells
83.3 μg/ml, F wells 27.77 μg/ml, E wells 9.26 μg/ml, D wells 3.08 μg/ml,
C wells 1.03 μg/ml and B wells 0.342 μg/ml wells. Consequently row H
had 100% drug concentration while those of B had only 0.137% of
the test sample. The plates were incubated for 48 h at 37 °C, 5% CO2
to allow drug to take effect on the growing cells. Addition of 10 μl of
MTT dye to each well was done after ensuring normal growth of the
cells in the plate under an inverted microscope. Plates were incubated
for another 4 h at 37 °C. Media was removed from the wells and
100 μl of DMSO added to dissolve the formazin. The plates were read
on a scanning multiwell spectrophotometer (Multiskan Ex labsystems)
at 562 nm and 620 nm as reference. Chloroquine (100 μg/ml highest
drug concentration) was used as a positive reference.
2.2.5. In vivo assay for the determination of safety (acute toxicity)
Themice were deprived of feed 12 h before and 3 h after administra-
tion of the plant extract. A total of 55 mice were used in the safety tests
and thesewere divided into 11 groups of 5mice each. One group received
an oral gavage of water and therefore served as a control. Five groups for
each extract received only one dose at concentrations of 500, 889.56,
1581.6, 2812.15 or 5000 mg/kg body weight once. The calculations of
dose levels are shown inAppendix C. Animalswere observed individually
after dosing at least oncewithin the ﬁrst 30 min, then periodically during
the ﬁrst 24 h and twice daily thereafter for a total of 14 days. The param-
eters of interest were; changes in skin and fur, eyes and mucous mem-
branes, respiratory, circulation, and autonomic and central nervous
system for signs of toxicity that may include tremors, convulsions, saliva-
tion, diarrhea, lethargy, somnolence or coma (OECD, 2001). The mice
were weighed on a daily basis and their weights recorded.
2.2.6. LD50 determination
This was carried out as described by Lorke (1983). At least ﬁve dose
levels ranging 500–5000 mg/kg body weight of each compound was
administered orally to the mice once. Five female mice were used per
dose level and the diluent (distilled water) was administered as the
control. Female mice were used in this study since literature surveys
of convectional LD50 tests indicate that although there is little differ-
ences in sensitivity between sexes where differences are observed fe-
males are slightly more sensitive (Gad and Chengelis, 1988). Graphs of
Table 2
Plant species and percentage yields of water extracts.
Botanical name Dry bark
weight (g)
Freeze dried
product (g)
(%) Yield of water
extracts
Prunus africana 150 13.452 8.968
Warburgia ugandensis 150 19.481 12.987
Table 3
Cytotoxicity (CC50) of plant extracts to Vero E6 cells.
Plant species Initial concentration tested (μg/ml) CC50 (μg/ml)
P. africana 250 104.08 ± 0.259
W. ugandensis 250 N250
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for probit is shown in Appendix D. The log dose that responded to probit
5 (50% deaths) was calculated from the graph equation and its anti-log
gave the LD50 (Finney, 1964).
2.3. Ethical clearance
Approval by KEMRI Scientiﬁc Steering Committee (SSC), KEMRI
Ethical Review Committee (ERC) and Animal Care and Use Commit-
tee (ACUC) was sought before study implementation.
2.4. Data management and analysis
Probit–log analysis was used for LD50 calculations. Mean weights of
mice in acute toxicity were obtained per group and means on the same
scale were compared using student T-test. All values were expressed as
mean ± standard error of mean and differences between the parame-
ters of estimate were deemed statistically signiﬁcant at p b 0.05.
3. Results
3.1. Yields of water extracts
The percentage yield of the water extract was calculated as follows:
Percentageyield ¼ Amountof freezedriedextract
Amountof grounddryplantextract
 100:
From 150 g of ground dry plant material, the percentage yield in
P. africana was 8.968% while that of W. ugandensis was 12.9873%. Raw
and percent yields are presented in Table 2.
3.2. Cytotoxicity assay
Growth of Vero E6 cells (%) incubated with high concentration of
P. africana extracts is as shown in Fig. 1. P. africana extracts had CC50
of 104.08 μg/ml (Table 3). Growth of Vero E6 cells (%) when incubated
with extracts of W. ugandensis is as shown in Fig. 2. Extracts of
W. ugandensis at the highest concentration tested did not lyse/cause37.00
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Fig. 1. Growth of Vero E6 cells (%) incubated with P. acytopathic effect to 50% of the cells and therefore the CC50 N 250 μg/ml
(Table 3).
3.3. Acute toxicity
3.3.1. Acute toxicity in mice treated with water extracts of P. africana
Five groups of mice were administered each with one dose of
P. africana water extract ranging from 500 to 5000 mg/kg body
weight. Signs of toxicity observed in mice treated with P. africana
at high dose levels (1581.64–5000 mg/kg body weight) include
hypo-activity, pilo-erection, low appetite and hyperventilation. There
was nomortality observedwithin 24 h for mice that received P. africana
extracts at 500 and 889.56 mg/kg, while there was 20% mortality at
1581.64 mg/kg, 60% at 2812.15 mg/kg and 100% mortality at
5000 mg/kg body weight (Table 4). Oral LD50 of P. africana was cal-
culated to be 2201.207 mg/kg body weight from probit analysis. The
LD50 is the anti-log of 3.3426609 (Fig. 3) which is log dose that
responded to probit 5 (dose that causes 50% deaths). Table for probit
used to plot the graph of probit against log dose (Appendix D). The
mice surviving after 24 h, survived for the entire 14 days of observa-
tion and their weights were noted. Their weights were plotted
(Fig. 4). The weights of mice that received 500, 889.56 and
1581.64 mg/kg body weight continued to increase and had no sig-
niﬁcant difference with that of controls (p N 0.05). Mice that re-
ceived 2812.15 mg/kg body weight had a decrease in weight the
ﬁrst day then continued increasing in weight in the consecutive
days of the study but had no signiﬁcant difference in weight from
that of control mice (p N 0.05).
The equation of this graph was used to calculate the log dose for
probit 5 (50%), from the graph the log dose that caused 50% animal
deaths was 3.343 whose anti-log was 2201.202 mg/kg body weight
which is the LD50 of P. africana stem bark extract.
3.3.2. Acute toxicity in mice treated with water extracts of W. ugandensis
Five groups of mice were administered each with one dose of
W. ugandensis water extract ranging from 500 to 5000 mg/kg body
weight. No signs of mortality were recorded at the doses tested. There
was also no mortality observed within 48 h for mice that received
W. ugandensis extracts in all dose levels (Table 5). W. ugandensis had
LD50 N 5000 mg/kg bodyweight. There was an increase in body weight
in all groups ofmice treatedwithW. ugandensis in all dose levels (Fig. 5)icana water extract (µg/ml)
1000.00100.000.00
fricanawater extracts at different concentrations.
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mice (p N 0.05).
4. Discussion
4.1. Yields of water extracts
From 150 g of ground dried barks of P. africana, a yield of 13.452 g
freeze dried water extract was obtained. The extraction was done
using 1500 ml of water equivalent to six glasses of water (250 ml
glass equivalent). Each glass of water extract therefore contains
2.242 g of freeze dried P. africana water extract (Appendix E).
Ground dry stem barks yield in W. ugandensis was 19.481 g and
using the same logic a glass of water extract contains 3.25 g of freeze
dried extract. W. ugandensis extracts yielded 4.0193% more than
those of P. africana in every 150 g of ground dried barks (Appendix
E). Traditional health practitioners normally prescribe a glass of
stem bark extract per day obtained by boiling a handful of dry stem
barks in water. This is taken as a dose for an adult irrespective of
age or body weight. This dose in the traditional setting is believed
to be safe and effective against ailments according to the THP
(Khalid and El Kamali, 1996; Kokwaro, 1976). Therefore if the same
glass measure (250 ml) is used in the treatment of ailments, the pa-
tients receive more concentration of W. ugandensis than P. africana
per glass in a boiled plant extract. However this does not imply
that W. ugandensis is more efﬁcacious than P. africana.
4.2. Cytotoxicity assay
Viable E6 cells take in MTT into their mitochondria; where mito-
chondrial succinate dehydrogenase reduced it to formazan crystals
which are insoluble and on the addition of a detergent it solubilizes
forming a purple color. The intensity of the color is an indication of
cell activity/viability and this was read as absorbance from a spectro-
photometer (Mosmann, 1983). Where the drug was cytotoxic the
cells underwent apoptosis or had inhibited growth and as such had
little absorbance. From the results of the MTT assay, CC50 of P. africanaTable 4
Acute toxicity in mice treated with P. africana water extracts.
Concentration
of plant extract
(mg/kg)
Number
of mice
that died
Total mice
treated
% mortality Log concentration Probit
500 0 5 0 0
889.56 0 5 0 2.949175
1581.64 1 5 20 3.199108 4.16
2812.15 3 5 60 3.449038 5.25
5000 5 5 100 3.69897 5.25was 104.08 μg/ml. Albeit, CC50 is the concentration of the extract that
lysis or causes cytopathic effect on 50% of the cells. P. africana extract
was classiﬁed as not cytotoxic according to the criteria of Rukunga
and Simons (2006). According to the classiﬁcation, cytotoxicity was
classiﬁed as: Cytotoxic at CC50 b 2 μg/ml, moderately cytotoxic at CC50
2–89 μg/ml and not cytotoxic at CC50 N 90 μg/ml. Subsequently, other
studies have demonstrated P. africana extracts as non-toxic, where cy-
totoxicity was N100 μg/ml (Tolo et al., 2006).
In accord to the Rukunga and Simons' (2006) classiﬁcation,
W. ugandensis was not cytotoxic at 250 μg/ml highest concentration
tested and therefore classiﬁed as not cytotoxic at ≥250 μg/ml.
Therefore CC50 for W. ugandensis was N 250 μg/ml. W. ugandensis
stem bark extracts have been reported to have no signiﬁcant cytotoxic-
ity effect on infected BALB/c macrophages in vitro at 1000 μg/ml and
were recommended as safe for use in further in vivo studies (Githinji
et al., 2010). Moreover, W. ugandensis extracts were determined to be
non-cytotoxic to Vero cells at 100 μg/ml (Ngure et al., 2009). However,
a cytotoxic sesquiterpene, characterized as muzigadial was isolated
from W. ugandensis (Olila et al., 2001) and it was highly toxic in the
brine shrimp assay. It is critical to note, in all these studies, the stem
bark extracts were not cytotoxic to Vero cells despite the fact that the
stem barks were sourced from different localities in Kenya. The CC50
values of the two extract indicate that the extracts are not toxic to the
Vero cells and thus are safe to use as herbal remedies.0
1
2
3
3 3.2 3.4 3.6 3.8
Log of Dose concentration
Fig. 3. Plot of probit against log dose of P. africana bark extracts.
Fig. 4.Weight of groups of mice treated with different doses of P. africanawater extracts.
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Scientiﬁc ﬁndings have pointed out that many plants used as food
and traditional medicine are potentially toxic, mutagenic and carci-
nogenic (Schimmer et al., 1994) yet, very little evidence of systemat-
ic screening done on such plants. On administration of single doses of
W. ugandensis to mice, nomortality was observed even at the highest
concentration tested. Based on the scale of Loomis and Hayes (1996)
classiﬁcation of toxicity (Appendix F),W. ugandensiswas classiﬁed as
relatively harmless with LD50 N 5000 mg/kg body weight. Another
pointer to the safety of W. ugandensis stem bark extracts was that,
all the animals that received treatment with the extracts stayed
alive for the entire period of study and the mean weights increased
progressively with no signiﬁcant difference from those of controls.
The results showed that the stem bark water extracts of W.
ugandensis were safe to use in mice as herbal medicine at the doses
tested. Correspondingly, all parts of W. ugandensis have been shown
to be edible and that leaves, barks, young shoots and fruits are used as
food and medicine (Kokwaro, 1976; Mbuya et al., 1994). Suggesting
that, the plant is safe for use in human. Besides,W. ugandensis bark ex-
tracts have been used for ages for treatment of stomachworms andma-
laria in Baringo Kenyawith no adverse effects (Henke, 1994)while non-
toxicity has been noted in vitro in BALB/c macrophages (Githinji et al.,
2010). These augmentW. ugandensis safety for use as a herbal extract.
4.4. Acute toxicity of P. africana extracts
Aqueous extracts of P. africanaweremildly toxic to rats after repeated
daily oral administration of 1000 mg/kg body mass (Gathumbi et al.,
2000). There was no repeated therapy in the present study. Also, when
P. africana extracts were administered at 500 and 889.56 mg/kg body
weight dose levels, no mortality was noted in the BALB/c mice. Equally,
P. africana stem bark extracts were determined to be non-toxic at
therapeutic dose of 500 mg/kg bodyweight (Tolo et al., 2006). Lethal
dose (LD50) for P. africana was calculated by probit analysis to be
2201.207 mg/kg body weight. Based on the scale of Loomis and
Hayes' (1996) classiﬁcation of toxicity (Appendix F), P. africana
was classiﬁed as slightly toxic with an LD50 of 2201.207 mg/kg
body weight. Toxic signs were not noted in the present outcomesTable 5
Acute toxicity in mice treated withW. ugandensis stem bark extracts.
Concentration of plant extract
(mg/kg)
Number of mice that
survived
Number of mice
that died
Total
889.56 5 0 5
1581.64 5 0 5
2812.15 5 0 5
5000.00 5 0 5at 1000 mg/kg body weight. Therefore the toxic signs recorded in
the repeated daily oral administration in the previous ﬁndings,
would have been due to bio-accumulation of the extracts in the sys-
tems leading to high concentration of the medicine resulting to mild
toxicity (Gathumbi et al., 2000). It can also be deduced that the dif-
ferences in toxicity could be attributed to different factors such as;
the stem bark extracts were from different plants of different ages,
growing in different localities and storage periods owing to the fact
that the drugs extracted are at times stored before use. The factors
would be worthy to consider in proﬁling the toxicity of the stem
bark extracts of P. africana.
Observational studies by clinicians have reported rare complains
of diarrhea, constipation, dizziness and visual disturbances as ad-
verse effects of P. africana among individuals under the medicinal
therapy for varied condition (Andro and Riffaud, 1995; Murray,
1995). The current study had mortality in BALB/c mice on adminis-
tration of higher doses (1581.6–5000 mg/kg body weight) of P. afri-
cana stem bark extracts. Signs of toxicity such as increased breathing
rate and loss of body balance were also evident in the animals. This
implies that doses above the LD50 were having lethal effects in the
mice. Lower doses (b1581.6 mg/kg body weight) had no adverse ef-
fects in the mice. This corresponded to the studies that reported the
absence of any signiﬁcant deleterious effects of P. africana at concen-
trations of 100 mg/kg body weight (Andro and Riffaud, 1995;
Murray, 1995), while pointing out on its constituents anti-
carcinogenic and anti-mutagenic properties both in vitro and
in vivo (Ishani et al., 2000). Mean weight loss for the ﬁrst few days
in the group of mice that received oral gavage of P. africana extract
at 2812.15 mg/kg body weight accompanied the toxic signs noted.
Nevertheless, weight gain or loss can be caused by a number of fac-
tors includingmotivation, eating behaviors, amount of activity, over-
all health metabolism and stress (Ekpo and Pretorius, 2008;
Pretorius et al., 2007). Low appetite was noted in mice administered
with the higher dose levels of the extract hence a potent factor to
changes in animal physiology leading to abated body weight and sur-
vival (Marti et al., 1994; Ottenweller et al., 1992; Retana-Márquez
et al., 2003). In one study using restraint stress, rats lost weight and
remained hypophagic until a few days after the stress had ended
(Harris et al., 1998). If stress would have caused weight loss in mice
then, all the groups could have lostweight andwould have had a signif-
icant differencewith that of the control but thiswas not the case. There-
fore, loss of weight in the ﬁrst fewdays and less progressiveweight gain
in the animals treated with 2812.15 mg/kg body weight compared to
controls and other treated groups would be attributed to; the drug
exhibiting inhibitory effects in the organ systems or interference with
cell functioning (Gathumbi et al., 2000).
All themice that survived the entire 14 days of study in acute tox-
icity assay had their weight not different from those of control indic-
ative that the lower doses were safe to use in mice. The survival of
Fig. 5.Weight of groups of mice treated with different doses ofW. ugandensiswater extracts.
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doses less than the LD50 is in coherence with in vivo tests in rats. Con-
cisely, P. africana stembarkwater extracts did not cause clinical or path-
ological abnormalities in rats at daily doses of up to 1000 mg/kg for
8 weeks (Gathumbi et al., 2002). In view of the contention, P. africana ex-
tracts are evidently being used for treatment of prostrate hyperplasia
as reported by Awang (1997). Despite the medicinal gains and ad-
vancement in utilization of P. africana extracts, the discourse points
to the need for further validation of biochemical and hematological
effects especially in cases of prolonged and repeated therapy.
5. Conclusion and recommendations
In the present study, a preliminary determination of safety of the
two selected medicinal plants commonly used by communities in
Kenya for treatment of asthma was achieved in BALB/c mice. The ﬁnd-
ings revealed that the bark extract doses of P. africana andW. ugandensis
administered had no obvious deleterious effect in the BALB/c mice. Thisinformation augments observational studies and forms a basis for fur-
ther research for validation and development of the extracts as possible
alternative therapies for management of asthma. To conﬁrm on the
non-toxic nature of P. africana andW. ugandensis, the effect that various
factors such as the growth stage and maturity of the plant, the speciﬁc
parts of the plant (leaves, roots, ﬂowers and seeds), seasonal variations
and storage conditions as well as where the plant is growing should be
looked into. Further, investigations should be done using puriﬁed com-
pounds andneed to plan for future pre-clinical and clinical studies of the
medicinal plants be considered.
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and permission to publish the work.Appendix A. Photographs of P. africana and its stem bark water extract
Appendix B. Photographs ofW. ugandensis and its stem bark water extract
% 0 1 2 3 4 5 6 7 8 9
0 – 2.67 2.95 3.12 3.25 3.36 3.45 3.52 3.59 3.66
10 3.72 3.77 3.82 3.87 3.92 3.96 4.01 4.05 4.08 4.12
20 4.16 4.19 4.23 4.26 4.29 4.33 4.36 4.39 4.42 4.45
30 4.48 4.50 4.53 4.56 4.59 4.61 4.64 4.67 4.69 4.72
40 4.75 4.77 4.80 4.82 4.85 4.87 4.90 4.92 4.95 4.97
50 5.00 5.03 5.05 5.08 5.10 5.13 5.15 5.18 5.20 5.23
60 5.25 5.28 5.31 5.33 5.36 5.39 5.41 5.44 5.47 5.50
70 5.52 5.55 5.58 5.61 5.64 5.67 5.71 5.74 5.77 5.81
80 5.84 5.88 5.92 5.95 5.99 6.04 6.08 6.13 6.18 6.23
90 6.28 6.34 6.41 6.48 6.55 6.64 6.75 6.88 7.05 7.33
– 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
99 7.33 7.37 7.41 7.40 7.51 7.58 7.65 7.75 7.88 8.09
189L.W. Karani et al. / South African Journal of Botany 88 (2013) 183–190Appendix C. Dose calculation in acute toxicity by
Lorke's (1983) formula
r ¼
ﬃﬃﬃ
L
l
n−1
r
Key:
r ratio
n number of doses (5)
L largest dose level
l smallest dose level
r ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
5000 mg=kg=day
500 mg=kg=day
4
s
¼
ﬃﬃﬃﬃﬃﬃ
104
p
¼ 1:778
Dose1 ¼ 5000 mg=kg=day;
Dose 2 ¼ 5000 mg=kg=day
1:778
¼ 2812:148 mg=kg=day
Dose3 ¼ 2812:14 mg=kg=day
1:778
¼ 1581:6358 mg=kg=day
Dose4 ¼ 1581:6358 mg=kg=day
1:778
¼ 889:559 mg=kg=day
Dose5 ¼ 500 mg=kg=day:Appendix D. Transformation of percentages to probitsAppendix E. Calculation of amount of freeze dried extract per glass
(250 ml glass)
P. africana: 150 g dry barks extracted with 1500 ml/6 glasses of
water yields 13.452 g,
1glasscontains
13:452 g
6
¼ 2:242 gof freezedriedstembarkextract:
W. ugandensis: 150 g dry stem barks extracted with 1500 ml/6
glasses of water yields 19.481 g
1glasscontains
19:481 g
6
¼ 3:247 gof freezedriedstembarkextract:
190 L.W. Karani et al. / South African Journal of Botany 88 (2013) 183–190Percentage quantity difference between P. africana andW. ugandensis
freeze dried stem bark water extracts from 150 g of dry ground stem
barks:
19:481−13:452
150
 100 ¼ 4:019%:
Appendix F. Loomis and Hayes' (1996) classiﬁcation of toxicity1 or less Extremely toxic
1–50 Highly toxic
50–500 Moderately toxic
500–5000 Slightly toxic
5000–15,000 Practically non-toxic
More than 15,000 Relatively harmlessReferences
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